Pagina 2 - I migliori medici per il trattamento di Tumore renale - TOP-103 medici

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Oncologist-mammologist

Treatment of mastopathy, which causes pain and swelling of the mammary gland

Treatment of large breast cysts without surgical aspiration

Treatment of duct ectasia (dilation) and galactorrhea

Obtaining a smear from the secretion of the mammary gland

Treatment of adenosis and other precancerous diseases of the mammary gland

Biopsy of pathological formations on the skin of the mammary gland

Hormonal treatment for breast cancer

Treatment of precancerous diseases of other organs

Cancer Treatment

Symptomatic treatment of cancer patients

Mistletoe therapy and cancer treatment with high doses of vitamin C.

Elimination of complications and side effects of chemotherapy and radiation therapy

Pain Treatment for Cancer Patients (Natural Pain Relief and Life Extension)

Participant of many conferences and seminars with the participation of German doctors in Azerbaijan, as well as in Germany and Turkey.

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

• Education: 
•  
• 2001-2007: University of Ioannina Medical School, Greece.
• 2007: Degree in Medicine.
• 2013: Doctoral degree from the Medical School of the Johann Wolfgang Goethe University, Frankfurt (Dr. Med)
• 09.2016 – Today: Master’s in Healthcare Business Studies.

Professional experience:

04.2009 – 04.2013: Resident in the Department for Radiation Oncology, Klinikum Offenbach

05.2013 – 12. 2015: Senior physician in the Department for Radiation Oncology, Klinikum Offenbach

• 01.2016 – 06.2017: Senior physician in the Department of interventional Radiation Oncology, Medical Center Athens
•  
• 07.2017 – Today: Head of the Department of Radiation Oncology at the German Oncology Center, Limassol, Cyprus.

Il medico è specializzato nella gestione del cancro al seno, del colon-retto e dei tumori del sistema urogenitale. Con un'ampia esperienza dal 2014 presso l'Anadolu Medical Center, il medico ha precedentemente lavorato presso il Medical Park Hospital, l'Ospedale di Educazione e Ricerca Kocaeli Derince e l'Ospedale Regionale di Educazione e Ricerca di Erzurum. Il servizio militare del medico includeva un ruolo come specialista in Oncologia Medica presso l'Accademia Medica Militare di Gülhane.<\/p>

I successi educativi includono una laurea in medicina generale presso l'Università di Istanbul e specializzazioni in medicina interna e oncologia medica. Il medico è membro dell'Associazione Medica Turca, della Società Turca di Oncologia Medica e della Società Turca di Cancro del Polmone.<\/p>

Il dottor Serkan Keskin ha ottenuto il 1º posto a livello nazionale nel suo esame di abilitazione in Oncologia Medica. Lavora con trattamenti avanzati come l'immunoterapia presso il Memorial Şişli Hospital.

• Oltre 28 anni di esperienza nel trattamento di tumori complessi
• Utilizza tecniche avanzate, tra cui terapia mirata e chemioterapia
• È membro di società globali leader come ASCO ed ESMO
• Riconosciuto con il Premio per il Miglior Poster a un Congresso Nazionale sul Cancro
• Ha completato la sua formazione di specializzazione in oncologia presso l'Istituto di Oncologia dell'Università di Istanbul

La professoressa Yesim Yildirim è specializzata in immunoterapia del cancro e terapie mirate, con oltre 80 pubblicazioni e riconoscimento internazionale.

• Membro della Società Europea di Oncologia Medica (ESMO)
• Formata presso la Clinica per Melanoma e Cancro Renale del Mount Vernon Cancer Center
• Coautrice del 'Manuale di Trattamento Avanzato del Cancro'
• Professoressa presso l'Università di Haliç, Istanbul

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

Il medico è un oncologo medico e mammario certificato ECFMG e ESMO con oltre 20 anni di esperienza, specializzato nel trattamento del cancro solido, del cancro al seno, del colon-retto e del polmone. Dal 2016, il medico è specialista in oncologia medica presso l'Anadolu Medical Center.<\/p>

Il medico si è laureato presso l'Accademia Medica Militare di Gülhane con una laurea in medicina generale e ha completato specializzazioni in oncologia interna e medica. Il medico è stato professore e professore associato presso l'Accademia Medica Militare di Gülhane, contribuendo in modo significativo all'educazione medica.<\/p>

Con oltre 110 articoli sulla gestione del cancro, il medico è membro di diverse prestigiose organizzazioni oncologiche.<\/p>

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

Il medico si è laureato presso la Facoltà di Medicina dell'Università di Ankara e ha completato la formazione in medicina interna presso la Scuola di Medicina di Ankara GATA. Specializzandosi in oncologia medica e ematologia, il medico ha completato una borsa di studio clinica negli Stati Uniti. Pioniere in Turchia, il medico ha fatto parte del team che ha eseguito il primo trapianto di midollo osseo nel paese. Il medico ha servito come docente ospite in istituzioni prestigiose a Londra e in Svizzera. In possesso del Certificato Europeo di Oncologia Medica, il medico è membro fondatore sia della Società Turca di Oncologia Medica che del Gruppo Oncologico Turco. Il focus clinico include tumori al seno, gastrointestinali, polmonari, linfomi e mieloma.<\/p>

Il Prof. Zielinski dirige il più grande dipartimento di oncologia dell'Austria e ha fondato il Comprehensive Cancer Center Vienna – un leader mondiale nella medicina oncologica personalizzata.

• Oltre 40 anni di specializzazione in oncologia medica e immunoterapia
• Responsabile del Centro Oncologico di Vienna e del Centro Oncologico Internazionale della Wiener Privatklinik
• Ex Presidente del Central European Cooperative Oncology Group (CECOG)
• Pioniere nelle terapie oncologiche individualizzate basate sulla biologia del tumore

Education and Expertise

Selcuk University Meram Faculty of Medicine - Medical Education

Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization

Experience

Malatya State Hospital Internal Diseases Clinic

Ankara Oncology Hospital Medical Oncology Clinic

Erzurum Regional Training and Research Hospital Medical Oncology Clinic


AREAS OF INTEREST

Lung cancer

esophageal cancer

Gastric cancer

breast cancer

Gastrointestinal surgery

https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr 

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Specializzato nel cancro del rene con competenza in immunoterapia e terapia mirata – trattamenti all'avanguardia presso il Medical Center di Solingen.

• Oltre 15 anni in oncologia con specializzazione in cancro del rene
• Medico Primario presso un centro oncologico interdisciplinare certificato
• Attivo nella ricerca in biologia molecolare per trattamenti innovativi
• Membro di società oncologiche tedesche e americane

Il Prof. Keil è specializzato in radiologia diagnostica e interventistica per il cancro del rene, offrendo immagini di precisione e tecniche avanzate per casi complessi.

• Primario presso l'Ospedale Accademico di Solingen
• Esperto in risonanza magnetica (RM), tomografia computerizzata (TC) e radiologia interventistica
• Formazione sotto la guida del Prof. Christian K. Kuhl, un pioniere della radiologia
• Laureato con lode presso la Julius-Maximilians-Universität Würzburg

Oltre 1.100 procedure per il cancro renale eseguite – Il Prof. Jaeger è uno specialista di sarcomi di alto livello presso la Nordwest Klinik ed è stato nominato uno dei migliori oncologi della Germania per oltre 20 anni.

• 38 anni di esperienza in oncologia ed ematologia
• Professore di oncologia multidisciplinare presso l'Università Goethe
• Guida ricerche innovative su vaccini antitumorali personalizzati
• Membro del comitato di esperti dell'EORTC
• Pubblicazioni citate in oltre 7.000 fonti scientifiche